The 2020 Global Specialty Lens Symposium is just around the corner and will be held in Las Vegas from January 22 to 25, 2020. Our abstract submission window for papers and posters has been open since July and will close in less than 10 days on Oct. 1, 2019 at 5:00 p.m. Eastern. While we have received a great number of submissions to date, we would love to see more incredible clinical and research work presented at next year’s meeting. Topics do not need to be limited to specialty contact lenses; they span the fields of contact lenses and the ocular surface. For more information, please visit: https://www.eiseverywhere.com/website/2486/posters-free-papers.
Jason J. Nichols, OD, MPH, PhD
ABB Optical Group Reorganizes Services Under Three Business Groups
ABB Optical Group announced that it has reorganized its services and solutions into three new groups: ABB Contact Lens, ABB Labs, and ABB Business Solutions.
ABB Contact Lens is an authorized distributor for all major soft contact lens manufacturers and a manufacturer of custom soft and GP lenses. ABB Labs offers eyecare practitioners (ECPs) fabrication of a wide selection of brand-name digital lens designs and AR coatings, as well as its own proprietary products. ABB Labs’ fully automated laboratories feature multiple fabrication lines, onsite AR coating capabilities, as well as lens finishing centers and frames distribution.
ABB Business Solutions provides ECPs with operational solutions to help them attract and retain patients and drive efficiencies in their practices, according to the company. The company will collaborate with industry leaders to offer new products and services to its ECP customers. In addition, this group also features a practice performance optimization platform, vision care benefits optimization system, patient communication system, an automated contact lens reordering platform, and other services.
The five new solutions supporting ECPs are ABB Analyze, powered by Glimpse, which is a practice performance and dashboard analytics software; ABB AutoShip, which gives patients the convenience to order and receive their contact lenses when and where it works for them; ABB Educate, which provides online and in-person training for ECPs and optical staff; ABB Verify, which provides benefits and managed care verification technology; and ABB Connect, which is a loyalty-driving marketplace platform.
BostonSight Holds FitAcademy
BostonSight announced FitAcademy, its first-ever educational retreat for cornea and contact lens residents. Held on Sept. 21, 2019, BostonSight welcomed 23 cornea and contact lens residents from around the United States and Canada for a day-long intensive program designed to give clinicians the opportunity to improve scleral lens fitting, assessment, and management. Sponsors of FitAcademy included The John W. Henry Family Foundation, Contamac, Eaglet Eye, and Tangible Science.
VSP Optics Unveils Unity BioSync Contact Lenses
VSP Optics announced the launch of Unity BioSync Contact Lenses. The premium daily disposable spherical contact lens is made from a proprietary combination of a silicone hydrogel material and a proprietary polymer coating that is exclusive to Unity BioSync, according to the company.
The company also says that Unity BioSync is made with HydraMist, which features unique moisture-retaining polymers for an increased level of hydration throughout the day. The lenses have a base curve of 8.8mm and a diameter of 14.1mm. The power ranges include +8.00D to –10.00D. It also offers a reported Dk/t value of 150.
Unity BioSync will initially be available for patients through practices participating in the VSP Global Premier Program.
Zeiss and IDOC Forge Partnership
IDOC, Zeiss Vision Care US, and Zeiss Medical Technology announced a five-year agreement to bring Zeiss’ lab services, lens products, and medical equipment—including Zeiss UVProtect Technology, Zeiss DriveSafe lenses, Zeiss Clarus 700, Zeiss Cirrus HD-OCT, and more—to all 3,000+ IDOC independent optometrists across the United States.
Oasis Introduces Its New Line of Dietary Supplements
Oasis Medical Inc. unveiled its new dietary supplements, Oasis Tears Vision and Oasis Tears Omega 3. Oasis Tears Vision is a patent-pending formulation delivered in a small soft gel. It will be packaged as a 30-day supply. The company is accepting pre-orders for Oasis Tears Vision and Oasis Tears Omega 3, with product available later this year.
Over the last month, did you see a change in the frequency of children as patients in your office?
Your Interesting Case Photo Here in the Next Issue
Have you seen an interesting case lately? Would you like to share it with your colleagues? An image from that case could appear in Contact Lenses Today in the coming weeks!
We welcome photo submissions from our readers! It is easy to submit a photo for consideration for publishing in Contact Lenses Today. Simply visit http://www.cltoday.com/upload/upload.aspx to upload your image. Please include a detailed explanation of the photo and your full name, degree or title, and city/state/country.
S. Barry Eiden, OD
Contact Lens-Induced Dry Eye, Contact Lens-Associated Dry Eye, and Just Plain Old Dry Eye
Eyecare practitioners are faced with the challenge of differentiating between true underlying dry eye/ocular surface disease (DE/OSD) and contact lens (CL)-induced dryness on a daily basis. Treatment of true DE/OSD is a critical first step in achieving successful CL wear. A recent article was published that compared subjective and clinical outcomes in three study groups: asymptomatic CL wearers (ASYM); symptomatic CL wearers who become asymptomatic on lens removal; and symptomatic CL wearers whose symptoms do not resolve on lens removal.1
Ninety-two subjects completed the Berkeley Dry Eye Flow Chart (with and without lenses), ocular surface examinations, and a battery of questionnaires. Thirty-seven subjects (40%) were ASYM, 30 (33%) had CL-induced dry eye (CLIDE), and 25 (27%) had underlying physiological DE. Visual Analog Scale ratings, OSDI score, and SPEED score were significantly better for the ASYM group (P < 0.001) but did not distinguish CLIDE from DE. The DE group was significantly worse than were the CLIDE and ASYM groups, which were similar to each other, in precorneal noninvasive tear breakup time (8.2 seconds for the DE group versus 12.3 seconds for the CLIDE group and 14.3 seconds for the ASYM group; P = 0.002), anterior displacement of the line of Marx (P = 0.017), and superior conjunctival staining (P = 0.001).
The authors concluded that many CL wearers presenting with dryness symptoms have an underlying DE condition and will not respond to treatments involving changing lenses or solutions. Contradictory results from research studies of DE in CL wearers could be due in part to a failure to distinguish subjects who have symptoms due specifically to CL wear from those whose symptoms have underlying causes unrelated to CL wear.
Surely, it is important to diagnose underlying DE/OSD in all current or prospective contact lens wearers. A DE and OSD workup should be considered as an integral part of a comprehensive contact lens patient evaluation.
1. Molina K, Graham AD, Yeh T, et al. Not All Dry Eye in Contact Lens Wear Is Contact Lens-Induced. Eye Contact Lens. 2019 Sep 10. [Epub ahead of print]
OCULAR SURFACE UPDATE
Katherine Mastrota, MS, OD
An Aisle of Confusion
Recently, on an early Sunday morning, my best friend asked me for some eye advice for her 92-year-old mother, who had sprouted a concerning, angry, red eyelid lesion. My friend, my friend’s sister (who was with her mother), and I communicated on a three-way, photo-texting consultation regarding what to do for the eyelid.
The photo showed a small focal and injected chalazion. Of more interest, however, was the significant ectropion and debris-laden eyelashes of the affected eye. Although the eyelid bump was the family’s concern, the ectropion-related exposure was mine.
I sent my friend instructions for lid hygiene (commercial product suggestion) and liberal eye lubrication (branded suggestion) for her mother. Interestingly, her mother had a bottle of “house brand” generic artificial tears that she used—sometimes.
A half-hour later, four photos arrived on my phone. The photos were of multiple walls of artificial tears and other over-the-counter (OTC) eye drops as well as a fully stocked section of lid-cleaning products that were available at the local drugstore. To be honest, there were more than I even knew existed. Even with a specific product recommendation, selecting the correct product was a challenge because I hadn’t been detailed enough with my description.
Patients and professionals alike are fortunate to have many evolving OTC therapies for ocular surface concerns. Many older products that have served us well over the years are folded into our management choices and may confound the ultimate selection from the pharmacy shelf.
Be sensitive to the confusion that can ensue in the pharmacy. When recommending products, employ industry-supplied visual reminders to make identification easier or dispense these products in your office to ensure that your patients are complying with your therapy of choice.
The Prevalence of Bacteria, Fungi, Viruses, and Acanthamoeba from 3,004 Cases of Keratitis, Endophthalmitis, and Conjunctivitis
The definitive identification of ocular pathogens optimizes effective treatment. Although the types of ocular pathogens are known, there is less definitive information on the prevalence of causative infections including viruses, fungi, and protozoa. That was the focus of this retrospective laboratory review.
For this study, data used for laboratory certification were reviewed for the detection of bacteria, viruses, fungi, and protozoa from patients who had infectious keratitis, endophthalmitis, and conjunctivitis. The main outcome parameter was laboratory-positive ocular infection.
The distribution of infectious agents for keratitis (n = 1,387) (2004 to 2018) was bacteria, 72.1% (Staphylococcus aureus, 20.3%; Pseudomonas aeruginosa, 18%; Streptococcus spp., 8.5%; other gram-positives, 12.4%; and other gram-negatives, 12.9%); herpes simplex virus, 16%; fungi, 6.7%; and Acanthamoeba, 5.2%. For endophthalmitis (n = 770) (1993 to 2018), the bacterial distribution was coagulase-negative Staphylococcus, 54%; Streptococcus spp., 21%; S. aureus, 10%; other gram-positives, 8%; and gram-negatives, 7%. The distribution for conjunctivitis (n = 847) (2004 to 2018) was adenovirus, 34%; S. aureus, 25.5%; Streptococcus pneumoniae, 9%; Haemophilus, 9%; other gram-negatives, 8.8%; other gram-positives, 6%; coagulase-negative Staphylococcus, 4.5%; and chlamydia, 3.2%.
The authors concluded that an updated monitoring of ocular pathogens creates an awareness of the different infectious etiologies and the importance of laboratory studies. This information can determine treatment needs for infectious ocular diseases.
Kowalski RP, Nayyar SV, Romanowski EG, et al. The Prevalence of Bacteria, Fungi, Viruses, and Acanthamoeba From 3,004 Cases of Keratitis, Endophthalmitis, and Conjunctivitis. Eye Contact Lens. 2019 Aug 1. [Epub ahead of print]